Replimune Group, Inc. (REPL)
Replimune Group, Inc. (REPL) has a 20-report earnings history dating back to May 20, 2021. Its average absolute post-earnings move is ±4.14%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +7.32% (Feb 12, 2025) and its largest decline was -15.85% (Nov 07, 2023). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±4.14%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Feb 03, 2026 | ☀ PRE | $7.03 | $7.46 | $7.38 | 1,089,700 | +5.81% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $8.56 | $8.64 | $8.50 | 2,234,200 | -0.93% | open_in_new |
| Aug 07, 2025 | ☀ PRE | $5.51 | $5.56 | $5.48 | 5,852,800 | -0.36% | open_in_new |
| May 22, 2025 | ☀ PRE | $8.80 | $9.85 | $8.76 | 2,690,700 | +3.55% | open_in_new |
| Feb 12, 2025 | ☀ PRE | $12.36 | $13.85 | $13.79 | 930,300 | +7.32% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $12.49 | $12.60 | $12.19 | 461,200 | -2.48% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $9.42 | $9.82 | $9.45 | 442,000 | +2.72% | open_in_new |
| May 16, 2024 | ☀ PRE | $6.64 | $6.76 | $6.72 | 931,400 | -1.32% | open_in_new |
| Feb 08, 2024 | ☀ PRE | $8.50 | $8.50 | $7.72 | 1,469,300 | +4.04% | open_in_new |
| Nov 07, 2023 | ☀ PRE | $12.61 | $12.73 | $10.83 | 1,267,000 | -15.85% | open_in_new |
| Aug 03, 2023 | ☀ PRE | $20.24 | $20.27 | $19.25 | 1,163,000 | -9.69% | open_in_new |
| May 18, 2023 | ☀ PRE | $19.28 | $19.72 | $19.64 | 819,400 | +0.72% | open_in_new |
| Feb 09, 2023 | ☀ PRE | $28.07 | $28.07 | $25.51 | 596,100 | -9.12% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $18.93 | $20.21 | $19.44 | 133,500 | +1.2% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $20.50 | $21.63 | $20.45 | 160,400 | -0.2% | open_in_new |
| May 19, 2022 | ☀ PRE | $13.97 | $14.72 | $14.38 | 377,000 | +1.05% | open_in_new |
| Feb 03, 2022 | ☀ PRE | $18.32 | $19.08 | $18.25 | 341,100 | -0.71% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $33.05 | $33.87 | $33.33 | 358,500 | +0.51% | open_in_new |
| Aug 06, 2021 | ☀ PRE | $36.97 | $36.97 | $32.56 | 353,700 | -10.38% | open_in_new |
| May 20, 2021 | ☀ PRE | $35.00 | $36.60 | $35.91 | 232,200 | +4.75% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±4.14%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260603 | open_in_new SEC.gov |
| 8-K | 20260529 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260521 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
Frequently asked about REPL earnings
When does Replimune Group, Inc. report earnings next? expand_more
Replimune Group, Inc. (REPL)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does REPL stock move after earnings? expand_more
Over 20 reports, REPL has moved an average of ±4.14% the session after earnings, closing higher 50.0% of the time.
What was REPL's biggest post-earnings move? expand_more
REPL's largest post-earnings gain on record was +7.32% on Feb 12, 2025, and its largest decline was -15.85% on Nov 07, 2023.
Where can I find Replimune Group, Inc.'s SEC filings? expand_more
All of Replimune Group, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right